UBS Group AG - SONNET BIOTHERAPEUTC HLDNG I ownership

SONNET BIOTHERAPEUTC HLDNG I's ticker is and the CUSIP is 83548R105. A total of 20 filers reported holding SONNET BIOTHERAPEUTC HLDNG I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SONNET BIOTHERAPEUTC HLDNG I
ValueSharesWeighting
Q2 2022$7,000
-66.7%
24,651
-55.1%
0.00%
Q1 2022$21,000
+10.5%
54,955
+19.8%
0.00%
Q4 2021$19,000
+171.4%
45,888
+324.5%
0.00%
Q3 2021$7,000
-30.0%
10,810
+146.3%
0.00%
Q1 2021$10,000
-23.1%
4,389
-25.0%
0.00%
Q4 2020$13,000
-18.8%
5,855
+30.7%
0.00%
Q2 2020$16,0004,4810.00%
Other shareholders
SONNET BIOTHERAPEUTC HLDNG I shareholders Q3 2021
NameSharesValueWeighting ↓
IFP Advisors, Inc 2,000$13,0000.00%
View complete list of SONNET BIOTHERAPEUTC HLDNG I shareholders